BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

698 related articles for article (PubMed ID: 14755725)

  • 1. Clinical features of cerebral cavernous malformations patients with KRIT1 mutations.
    Denier C; Labauge P; Brunereau L; Cavé-Riant F; Marchelli F; Arnoult M; Cecillon M; Maciazek J; Joutel A; Tournier-Lasserve E; ;
    Ann Neurol; 2004 Feb; 55(2):213-20. PubMed ID: 14755725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical, magnetic resonance imaging, and genetic study of 5 Italian families with cerebral cavernous malformation.
    Battistini S; Rocchi R; Cerase A; Citterio A; Tassi L; Lando G; Patrosso MC; Galli R; Brunori P; Sgrò DL; Pitillo G; Lo Russo G; Marocchi A; Penco S
    Arch Neurol; 2007 Jun; 64(6):843-8. PubMed ID: 17562932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variable expression of cerebral cavernous malformations in carriers of a premature termination codon in exon 17 of the Krit1 gene.
    Lucas M; Costa AF; García-Moreno JM; Solano F; Gamero MA; Izquierdo G
    BMC Neurol; 2003 Jul; 3():5. PubMed ID: 12877753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spectrum and expression analysis of KRIT1 mutations in 121 consecutive and unrelated patients with Cerebral Cavernous Malformations.
    Cavé-Riant F; Denier C; Labauge P; Cécillon M; Maciazek J; Joutel A; Laberge-Le Couteulx S; Tournier-Lasserve E
    Eur J Hum Genet; 2002 Nov; 10(11):733-40. PubMed ID: 12404106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spectrum of genotype and clinical manifestations in cerebral cavernous malformations.
    Gault J; Sain S; Hu LJ; Awad IA
    Neurosurgery; 2006 Dec; 59(6):1278-84; discussion 1284-5. PubMed ID: 17277691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C329X in KRIT1 is a founder mutation among CCM patients in Sardinia.
    Cau M; Loi M; Melis M; Congiu R; Loi A; Meloni C; Serrenti M; Addis M; Melis MA
    Eur J Med Genet; 2009; 52(5):344-8. PubMed ID: 19454328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel KRIT1 gene mutation in a patient with cerebral and multiple spinal cavernous malformations.
    Lee YW; Lee ST; Cha JG; Park JH; Jeon BR; Lee YK; Kim JW; Ki CS
    Ann Clin Lab Sci; 2010; 40(3):290-4. PubMed ID: 20689144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutation and expression analysis of the KRIT1 gene associated with cerebral cavernous malformations (CCM1).
    Kehrer-Sawatzki H; Wilda M; Braun VM; Richter HP; Hameister H
    Acta Neuropathol; 2002 Sep; 104(3):231-40. PubMed ID: 12172908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent insights into cerebral cavernous malformations: the molecular genetics of CCM.
    Riant F; Bergametti F; Ayrignac X; Boulday G; Tournier-Lasserve E
    FEBS J; 2010 Mar; 277(5):1070-5. PubMed ID: 20096038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of cardiovascular risk factors with disease severity in cerebral cavernous malformation type 1 subjects with the common Hispanic mutation.
    Choquet H; Nelson J; Pawlikowska L; McCulloch CE; Akers A; Baca B; Khan Y; Hart B; Morrison L; Kim H
    Cerebrovasc Dis; 2014; 37(1):57-63. PubMed ID: 24401931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of gradient-echo magnetic resonance imaging in the diagnosis of familial cerebral cavernous malformation.
    Lehnhardt FG; von Smekal U; Rückriem B; Stenzel W; Neveling M; Heiss WD; Jacobs AH
    Arch Neurol; 2005 Apr; 62(4):653-8. PubMed ID: 15824268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Novel CCM1/KRIT1 Heterozygous Nonsense Mutation (c.1864C>T) Associated with Familial Cerebral Cavernous Malformation: a Genetic Insight from an 8-Year Continuous Observational Study.
    Yang C; Nicholas VH; Zhao J; Wu B; Zhong H; Li Y; Xu Y
    J Mol Neurosci; 2017 Apr; 61(4):511-523. PubMed ID: 28255959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Truncating mutations in CCM1, encoding KRIT1, cause hereditary cavernous angiomas.
    Laberge-le Couteulx S; Jung HH; Labauge P; Houtteville JP; Lescoat C; Cecillon M; Marechal E; Joutel A; Bach JF; Tournier-Lasserve E
    Nat Genet; 1999 Oct; 23(2):189-93. PubMed ID: 10508515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel deletion mutation in CCM1 gene (krit1) is detected in a Chinese family with cerebral cavernous malformations.
    Ji BH; Qin W; Sun T; Feng GY; He L; Wang YJ
    Yi Chuan Xue Bao; 2006 Feb; 33(2):105-10. PubMed ID: 16529293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel CCM1 gene mutation causes cerebral cavernous malformation in a Chinese family.
    Zhao Y; Xie L; Li P; Song J; Qu T; Fan W; Chen H; Chen D; Lu D; Zhou L; Mao Y
    J Clin Neurosci; 2011 Jan; 18(1):61-5. PubMed ID: 20884211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A splice-site mutation in CCM1/KRIT1 is associated with retinal and cerebral cavernous hemangioma.
    Kitzmann AS; Pulido JS; Ferber MJ; Highsmith WE; Babovic-Vuksanovic D
    Ophthalmic Genet; 2006 Dec; 27(4):157-9. PubMed ID: 17148043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphisms in inflammatory and immune response genes associated with cerebral cavernous malformation type 1 severity.
    Choquet H; Pawlikowska L; Nelson J; McCulloch CE; Akers A; Baca B; Khan Y; Hart B; Morrison L; Kim H;
    Cerebrovasc Dis; 2014; 38(6):433-40. PubMed ID: 25472749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel CCM1, CCM2, and CCM3 mutations in patients with cerebral cavernous malformations: in-frame deletion in CCM2 prevents formation of a CCM1/CCM2/CCM3 protein complex.
    Stahl S; Gaetzner S; Voss K; Brackertz B; Schleider E; Sürücü O; Kunze E; Netzer C; Korenke C; Finckh U; Habek M; Poljakovic Z; Elbracht M; Rudnik-Schöneborn S; Bertalanffy H; Sure U; Felbor U
    Hum Mutat; 2008 May; 29(5):709-17. PubMed ID: 18300272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a c.601C>G mutation in the CCM1 gene in a kindred with multiple skin, spinal and cerebral cavernous malformations.
    Haghighi A; Fathi D; Shahbazi M; Motahari MM; Friedman B
    J Neurol Sci; 2013 Nov; 334(1-2):97-101. PubMed ID: 24007869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Highly variable penetrance in subjects affected with cavernous cerebral angiomas (CCM) carrying novel CCM1 and CCM2 mutations.
    Gianfrancesco F; Cannella M; Martino T; Maglione V; Esposito T; Innocenzi G; Vitale E; Liquori CL; Marchuk DA; Squitieri F
    Am J Med Genet B Neuropsychiatr Genet; 2007 Jul; 144B(5):691-5. PubMed ID: 17440989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.